Diabetic Wound Care That Delivers in Baltimore, MD

The numbers that actually change how you stock in Baltimore

If a sales sheet cannot tell you that Baltimore is JL (Novitas Solutions) and that adult diabetes here is 14.4% (PLACES 2023), it is selling units, not a program. That is the diabetic wound care conversation we actually have.

The chart problems we still see in MD

• CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure. Adult obesity in Baltimore is 38.1% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JL review. Product is the last step, not the first.
• Chronic wounds that stall past 30 days are the typical entry point for cellular/tissue products. CDC diabetes prevalence is the epidemiologic backdrop; JL coverage rules are the billing backdrop. Both have to be true on the same chart.
• In a city of 500k–1M, vendor noise is the operational problem: too many look-alike allograft flyers, too little chain-of-custody paperwork. Hawk Medical ships nationwide with HCT/P documentation; we do not invent a Baltimore street address.

City rate, state belt, federal LCD — keep the grains

Three grains, kept separate on purpose. City: Census 585,708 and CDC PLACES crude rates. State: Maryland Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 14.4% of adults in Baltimore have diagnosed diabetes — 2.4 points above the U.S. 12% figure.

Do this before you expand SKUs